Vasa Denticity

What does Vasa Denticity do?

Vasa Denticity Ltd is a small-cap company in the miscellaneous industry, incorporated in 2016 and converted to a public company in 2023, reporting net sales of 73 Cr and a net profit of 4 Cr for the quarter ending March 2025. Key metrics include a P/E ratio of 62.00 and a market cap of Rs 1,057 Cr.

Overview: <BR>Vasa Denticity Ltd operates in the miscellaneous industry and is categorized as a small-cap company.<BR><BR>History: <BR>Vasa Denticity Ltd was originally incorporated as a Private Limited Company in 2016 and later converted to a Public Company in March 2023. The most recent quarterly results report net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 73 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 4 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 1,057 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 62.00 <BR>Industry P/E: 32 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.08 <BR>Return on Equity: 22.09% <BR>Price to Book: 13.75 <BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

When is the next results date for Vasa Denticity?

No Upcoming Board Meetings

Has Vasa Denticity declared dividend?

No Dividend History Available

Who are the peers of the Vasa Denticity?

Vasa Denticity's peers include Knowledge Marine, R M Drip & Sprin, Kokuyo Camlin, and others. It has average management risk and capital structure, with a 1-year return of 6.40%, lower than R M Drip & Sprin's 262.00% but higher than Trident Techlabs' -38.07%.

Peers: The peers of Vasa Denticity are Knowledge Marine, R M Drip & Sprin, Kokuyo Camlin, Uniphos Enter., Trident Techlabs, Creative Newtech, Linc, Repro India, and Midwest Gold.<BR><BR>Quality Snapshot: Excellent management risk is observed at Knowledge Marine, while Average management risk is found at Vasa Denticity, Trident Techlabs, Creative Newtech, Linc, Repro India, and Everest Inds., and the rest. Growth is Excellent at Knowledge Marine, Vasa Denticity, R M Drip & Sprin, and Trident Techlabs, while Good growth is noted at Creative Newtech, and Average growth is seen at Kokuyo Camlin, Uniphos Enter., Linc, Repro India, and Everest Inds., and the rest. Capital Structure is Excellent at Knowledge Marine and Vasa Denticity, while Average capital structure is found at Creative Newtech and Linc, and Below Average at R M Drip & Sprin, Kokuyo Camlin, Uniphos Enter., Trident Techlabs, Repro India, and the rest.<BR><BR>Return Snapshot: R M Drip & Sprin has the highest 1-year return at 262.00%, while Trident Techlabs has the lowest at -38.07%. Vasa Denticity's 1-year return of 6.40% is significantly lower than R M Drip & Sprin's but higher than Trident Techlabs'. Additionally, Trident Techlabs, Creative Newtech, and Midwest Gold have negative six-month returns.

Who are the top shareholders of the Vasa Denticity?

The top shareholders of Vasa Denticity include Vikas Agarwal with 37.94%, six Foreign Institutional Investors holding 3.54%, and Ashish Kacholia as the highest public shareholder with 3.66%. Individual investors collectively own 24.62% of the company.

The top shareholders of Vasa Denticity include the promoters, who hold the majority of the shares. The promoter with the highest holding is Vikas Agarwal, with 37.94%. Additionally, there are six Foreign Institutional Investors (FIIs) collectively holding 3.54% of the shares, and one mutual fund scheme holds 0.31%. The highest public shareholder is Ashish Kacholia, who owns 3.66%. Individual investors together hold 24.62% of the company.

How big is Vasa Denticity?

As of 24th July, Vasa Denticity Ltd has a market capitalization of 1,021.00 Cr, with Net Sales of 247.69 Cr and a Net Profit of 16.96 Cr reported in the latest four quarters. The balance sheet for March 2024 shows Shareholder's Funds of 68.34 Cr and Total Assets of 85.29 Cr.

As of 24th July, Vasa Denticity Ltd has a market capitalization of 1,021.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Vasa Denticity reported Net Sales of 247.69 Cr and a Net Profit of 16.96 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 68.34 Cr and Total Assets of 85.29 Cr.

How has been the historical performance of Vasa Denticity?

Vasa Denticity's historical performance from March 2024 to March 2025 shows significant growth, with net sales increasing to 249.37 Cr from 169.73 Cr, and profit after tax rising to 16.90 Cr from 15.08 Cr. Despite a decline in operating and PAT margins, the company maintained stable total liabilities and assets, with a positive cash flow of 3.00 Cr.

Answer:<BR>The historical performance of Vasa Denticity shows a positive trend in key financial metrics from March 2024 to March 2025.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Vasa Denticity reported net sales of 249.37 Cr, a significant increase from 169.73 Cr in March 2024. Total operating income mirrored this growth, reaching 249.37 Cr compared to 169.73 Cr the previous year. The company's total expenditure also rose to 226.44 Cr from 150.69 Cr, with notable increases in the purchase of finished goods and employee costs. Operating profit (PBDIT) increased to 24.87 Cr from 20.47 Cr, while profit before tax rose to 23.12 Cr from 19.41 Cr. The profit after tax improved to 16.90 Cr from 15.08 Cr, leading to a consolidated net profit of 16.97 Cr, up from 15.08 Cr. Earnings per share (EPS) also saw an increase, reaching 10.21 compared to 9.41 in the prior year. However, operating profit margin and PAT margin experienced a decline, with operating profit margin at 9.2% and PAT margin at 6.78%. On the balance sheet, total liabilities remained stable at 85.29 Cr, while total assets were also consistent, reflecting a solid financial position. Cash flow from financing activities was notably positive at 36.00 Cr, contributing to a net cash inflow of 3.00 Cr, resulting in a closing cash and cash equivalent of 4.00 Cr.

Is Vasa Denticity overvalued or undervalued?

As of November 14, 2025, Vasa Denticity is considered overvalued with a PE ratio of 63.97, significantly higher than its peers, and has underperformed the Sensex with a year-to-date return of -21.24%.

As of 14 November 2025, Vasa Denticity's valuation grade has moved from fair to expensive, indicating a shift towards overvaluation. The company is currently assessed as overvalued, with a PE ratio of 63.97, an EV to EBITDA ratio of 45.79, and a PEG ratio of 13.62. These figures suggest that the stock is trading at a premium compared to its earnings growth potential.<BR><BR>In comparison to its peers, Vasa Denticity's valuation metrics are significantly higher than those of Altius Telecom, which has a PE ratio of 51.5, and Sagility, which is valued fairly with a PE of 31.2. This stark contrast highlights Vasa Denticity's overvaluation in the market. Additionally, the company's recent stock performance has underperformed against the Sensex, with a year-to-date return of -21.24% compared to the Sensex's 9.58%, further reinforcing the notion that the stock may be overvalued at its current price of 579.70.

Is Vasa Denticity technically bullish or bearish?

As of December 1, 2025, Vasa Denticity's technical trend has shifted to a bearish outlook, supported by bearish MACD, moving averages, Bollinger Bands, and KST, with the RSI indicating a lack of momentum.

As of 1 December 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with a strong indication of weakness. The weekly MACD is bearish, and the daily moving averages confirm this bearish sentiment. The Bollinger Bands on the weekly chart also reflect a bearish trend, while the KST is bearish as well. The RSI shows no signal on both weekly and monthly time frames, indicating a lack of momentum. Overall, the combination of these indicators suggests a bearish outlook for Vasa Denticity.

Are Vasa Denticity Ltd latest results good or bad?

Vasa Denticity Ltd's latest results are concerning, showing a 71.28% drop in net profit and a multi-quarter low operating margin of 2.43%, indicating significant operational challenges despite a year-on-year revenue growth of 14.85%. Overall, the results are classified as bad, suggesting a cautious approach for investors.

The latest results for Vasa Denticity Ltd are concerning, indicating a significant decline in profitability. In Q3 FY26, the company reported a net profit of ₹1.37 crore, which reflects a dramatic drop of 71.28% compared to the previous quarter and a 65.58% decline year-on-year. The operating margin also fell to 2.43%, marking a multi-quarter low and raising questions about the company's operational efficiency.<BR><BR>While revenue showed a slight decline of 1.07% quarter-on-quarter, it did grow by 14.85% year-on-year, suggesting stable demand for their products. However, the sharp drop in profitability, coupled with rising employee costs and deteriorating margins, highlights serious operational challenges that the company is facing.<BR><BR>Overall, the results can be classified as bad, given the significant erosion in profitability and the implications for the company's business model and competitive positioning in the dental products distribution market. Investors may need to approach this situation with caution, as the outlook appears challenging.

Should I buy, sell or hold Vasa Denticity Ltd?

Why is Vasa Denticity Ltd falling/rising?

As of 07-Feb, Vasa Denticity Ltd's stock price is at 568.40, down 4.12%, significantly underperforming the Sensex. The stock shows a consistent downward trend, with declining investor interest and poor financial results contributing to its negative outlook.

As of 07-Feb, Vasa Denticity Ltd's stock price is falling, currently at 568.40, reflecting a change of -24.45 (-4.12%). The stock has underperformed significantly compared to the benchmark Sensex, with a 1-week decline of -5.63% while the Sensex gained +1.47%. Over the past year, Vasa Denticity has generated a return of -15.39%, contrasting sharply with the Sensex's +8.86% return.<BR><BR>Today's performance indicates that the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, suggesting a consistent downward trend. Additionally, there has been a notable decline in investor participation, with delivery volume dropping by -23.91% compared to the 5-day average, indicating reduced interest from investors.<BR><BR>The company's recent financial results have also contributed to the stock's decline. In the December quarter, the profit after tax (PAT) fell by -65.1% compared to the previous four-quarter average, and the operating profit to net sales ratio reached its lowest point at 2.43%. Furthermore, the company's return on equity (ROE) stands at 9.2, with a high price-to-book value of 5.8, suggesting an expensive valuation relative to its earnings growth.<BR><BR>Compounding these issues is the decreasing confidence from promoters, who have reduced their stake in the company by -4.85% over the previous quarter, now holding 60.75%. This reduction in stake may signal a lack of confidence in the company's future prospects. Overall, the combination of poor financial performance, declining investor interest, and reduced promoter confidence has led to the stock's current downward trajectory.

Which are the latest news on Vasa Denticity?